Adverse effects: 7b. metabolic ‐ skewed data ‐ average change value on lipid profile ‐ short term (up to 12 weeks)
Study	Intervention	Mean	SD	N
cholesterol ‐ total
Durgam 2014	Risperidone	4.6	34.6	140
Durgam 2014	Placebo	‐1.3	30.4	151
Heisterberg 2007	Risperidone	‐2.2	31.4	154
Heisterberg 2007	Placebo	‐14.2	32.0	149
HDL
Durgam 2014	Risperidone	‐0.6	10.1	140
Durgam 2014	Placebo	‐1.1	9.4	151
Heisterberg 2007	Risperidone	2.1	10.3	154
Heisterberg 2007	Placebo	‐0.7	6.8	149
LDL
Durgam 2014	Risperidone	3.8	30.6	140
Durgam 2014	Placebo	‐0.1	25.3	151
Heisterberg 2007	Risperidone	‐2.8	28.8	154
Heisterberg 2007	Placebo	‐7.5	29.8	149
triglycerides
Durgam 2014	Risperidone	6.3	84.2	140
Durgam 2014	Placebo	‐3.1	59.9	151
Heisterberg 2007	Risperidone	‐6.7	136.2	154
Heisterberg 2007	Placebo	‐27.9	104.4	149
VLDL
Heisterberg 2007	Risperidone	‐1.4	17.7	154
Heisterberg 2007	Placebo	‐3.7	16.9	149